Overactive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.
Incorporating patient-related sociodemographic factors into performance measurement systems is essential for providing an accurate assessment of the quality of care delivered.
Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Does this antihyperglycemic combination medication need to be added to a formulary?
There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
The greater use of generic prescription medications has been widely advocated as a policy solution to rising healthcare costs.
The Drug Supply Chain Security Act (DSCSA) will soon mandate end-to-end tracking of pharmaceuticals throughout the supply chain, with numerous benefits for health systems.
Hospital acquisitions and mergers have become common in today's health care environment.
This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins.
Taylor M. Weis, PharmD, BCOP, discusses NCCN guidelines for first-line therapy as well as the rationale behind the rapid change in treatment concepts for CLL.
The creation and continuous evaluation of a hospital’s formulary facilitates superior patient care, achieves therapeutic goals, and improves patient safety while curtailing expenses.
Current treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.
The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 aims to expedite the entry of lower-cost biosimilars and generics into the market.
The US Pharmacopeia (USP) Convention’s General Chapter draft guidelines have already raised the bar for hazardous drug management and imposed costs for compliance.
Groundbreaking studies on the diagnosis, treatment, and prevention of stroke and heart disease were presented at the American Heart Association's scientific meeting in November.
HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.
Summit provides comprehensive mix of content and education, including clinical, financial, supply chain, and industry trends.Â
A retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.
Seasonal flu should be a concern to any pharmacist who provides patient care in any type of setting.
A Message from American Pharmacists Association (APhA) President-elect, Dr. Sandra Leal.
Ilevro (nepafenac ophthalmic suspension) is approved to reduce pain and inflammation resulting from cataract surgery.
The recent California measles outbreak appears to have galvanized the public's attention in a way earlier outbreaks have not, putting the anti-vaccine movement on the defensive.
An interaction with passionate pharmacist and co-worker caused E. Ashley Gulyas, PharmD, to enroll in pharmacy school after nearly a decade of work as a pharmacy technician.
An automated reinforcement platform was shown to increase statin adherence by 34.6%.
The Office of Inspector General has called upon of the Centers for Medicare & Medicaid Services to make the reduction of improper payments for prescription drugs a priority in 2015.